Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
Cancer remains a leading cause of death worldwide. Despite many signs of progress, currently available cancer treatments often do not provide desired outcomes for too many cancers. Therefore, newer and more effective therapeutic approaches are needed. Oncolytic viruses (OVs) have emerged as a novel...
Guardado en:
Autores principales: | Masmudur M. Rahman, Grant McFadden |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/40fca3f2a9bb450a95a1daf95c759442 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Viruses as nanomedicine for cancer
por: Badrinath N, et al.
Publicado: (2016) -
Oncolytic Virotherapy
Publicado: (2016) -
Single-cell RNA sequencing reveals a strong connection between Gadd45g upregulation and oncolytic HSV infection in tumor tissue
por: Divya Ravirala, et al.
Publicado: (2021) -
An Agent-Based Model of Combination Oncolytic Viral Therapy and Anti-PD-1 Immunotherapy Reveals the Importance of Spatial Location When Treating Glioblastoma
por: Kathleen M. Storey, et al.
Publicado: (2021) -
The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors
por: Kyle M. Pierce, et al.
Publicado: (2021)